These meal delivery services will help you take the guesswork out of planning healthy, balanced meals so you can meet your ...
Weight Loss & Vitality held its grand opening Friday, Sept. 19, in a new office on Osborn Avenue in Riverhead, next to ...
Pfizer’s Metsera acquisition boosts its obesity/GLP-1 pipeline and revenue outlook. See why I'm cautiously upgrading my ...
Getting enough quality sleep is emerging as a key factor in weight control, and it can be treated clinically to optimize ...
Longevity doctors warn GLP-1 drugs may cost patients muscle, not just fat. ShapeScale’s 3D scans reveal the loss—and help ...
Zion Williamson showed off his body transformation at Pelicans media day following boxing workouts and football field drills with trainer Daniel Bove this summer.
GLP-1 medications like Ozempic and Wegovy typically require a doctor’s evaluation and a prescription, as well as frequent ...
The regulatory landscape continues to evolve for muscle preservation drugs in the treatment of obesity. Based on FDA feedback on Veru’s clinical development program for enobosarm, FDA now guides that ...
People who receive regular phone support after losing weight are more likely to keep the pounds off—but getting extra calls ...
Pfizer has agreed to pay up to $7.3 billion for weight-loss drug developer Metsera in a deal that gets the New York drugmaker back into the burgeoning market for obesity drugs.
Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback